The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

A 40-year-old woman who was a frequent traveler suddenly found herself struggling to breathe after taking just a few steps. What began as unexplained fatigue and shortness of breath quickly disrupted ...

Having low lung function as a middle-aged smoker without airway obstruction raised the likelihood for all-cause mortality, ...

Pulmonary exacerbations are common in children with cystic fibrosis during the first 3 years of life and are associated with ...

Please provide your email address to receive an email when new articles are posted on . Pulmonary function testing results can indicate obstructive patterns. Providers must properly coach patients ...

This combined model achieved a high level of accuracy, suggesting that imaging data alongside basic clinical information could be effective for screening.

A major challenge facing primary care physicians arises when patients present with symptoms such as shortness of breath, fatigue, or difficulty breathing that can be respiratory or cardiovascular in ...

The lung provides an extensive surface area mediating gas exchange between epithelial cells and the capillaries in the alveolus. Since lung cells are in direct contact with environmental gases and ...